Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research focused on Cancer research and Breast cancer, with related work in Type 2 diabetes, Brushite, Cisplatin. Notable publications include 'Intensive Blood-Pressure Control in Patients with Type 2 Diabetes', 'The status and characteristics of urinary stone composition in China', and 'COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms'.
Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a)
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes
Giredestrant for Estrogen Receptor–Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study
The Age-Male-Albumin-Bilirubin-Platelets (aMAP) Risk Score Predicts Liver Metastasis Following Surgery for Breast Cancer in Chinese Population: A Retrospective Study
Identification of immunization-related new prognostic biomarkers for papillary renal cell carcinoma by integrated bioinformatics analysis
The status and characteristics of urinary stone composition in China
COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms
A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients
A novel small molecule inhibitor of MDM2-p53 (APG-115) enhances radiosensitivity of gastric adenocarcinoma
p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis
Correlation between myc/bcl-2 co-expression and myc/p53 co-expression and prognosis of diffuse large B-cell lymphoma
The prognostic significance of human epidermal growth factor receptor family protein expression in operable pancreatic cancer
STAT1 inhibits human hepatocellular carcinoma cell growth through induction of p53 and Fbxw7